Evolution of Chronic Inflammatory Skin Diseases

计划入组 5,000 人 · 首次发布于 2026 年 7 月 16 日

Serological Screening of Gastric Cancer in Wuxi Region

计划入组 5,000 人 · 首次发布于 2016 年 1 月 26 日

Advanced Therapies for Liver Metastases

计划入组 625 人 · 首次发布于 2020 年 11 月 10 日

Anti-angiogenic Ocular Gene Therapies (Advanced Vision Therapies)

Autologous Mesenchymal Stem Cells(Andalusian Initiative for Advanced Therapies)

VPS34 inhibitor (Global Cancer Technology/Barrow Neurological Insitute/Neuropore Therapies)

Andalusian Initiative for Advanced Therapies

Spain

WuXi AppTec, Inc.

China

WuXi Biologics Co., Ltd.

China

WuXi Companies Consider Asset Sales Amid US BIOSECURE Act Pressure

Minaris Advanced Therapies Launches as Global Cell Therapy CDMO Powerhouse

U.S. Cell and Gene Therapy CDMO Market Set for Explosive Growth, Projected to Reach $10.34 Billion by 2033